Back to search
FDAFDA · Food and drugs·Recall number D-0826-2016

Dextroamphetamine Sulfate Tablets USP, 5 mg, 100-count bottle, Rx only, Manufactured and Distributed by: CorePharma, LLC, Middlesex, NJ 08846, NDC 64720-215-10

Published April 27, 2016 · Recall initiated: March 14, 2016

Summary

FDA records drug Class II recall D-0826-2016, published April 27, 2016 and initiated March 14, 2016. Recalling firm: Impax Laboratories, Inc.; Status: Terminated; Reported quantity: 18,936 bottles; Lot: Lot #: 112565, Exp 03/17; 113458, Exp 08/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Impax Laboratories, Inc.
Distributor
Nationwide
Lot
Lot #: 112565, Exp 03/17; 113458, Exp 08/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextroamphetamine Sulfate Tablets USP, 5 mg, 100-count bottle, Rx only, Manufactured and Distributed by: CorePharma, LLC, Middlesex, NJ 08846, NDC 64720-215-10 recalled?

Yes. FDA published recall D-0826-2016 on April 27, 2016. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter